Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury

Summary

This phase II trial studies how well arginine works in treating patients with kidney injury caused by anti-VEGF drugs used in standard treatment for cancer. Arginine is a nutritional supplement that may control side effects of anti-cancer drugs such as high blood pressure and protein in the urine and may also help to improve kidney function in patients.

Timeline

Start

2018-10-23

Primary completion

2019-05-15

Completion

2019-05-15

Drugs

Indications